Magdalena Martullo is CEO of the EMS Group and a member of the Board of economiesuisse. She has also chaired the Economic Committee on the Board of scienceindustries – the association of the pharma/chemistry and biotech industries – for 15 years. During her business administration degree, she held various positions abroad and then worked in marketing and sales at Rivella and Johnson & Johnson. In addition to her roles in business, she is also politically active and since 2015 has been a SVP National Councillor in Grisons and Vice-President of the SVP Switzerland.
National Councilwoman and entrepreneur Magdalena Martullo-Blocher describes how she experienced the pandemic’s effects on her company. As is often described, the initial reaction was one of uncertainty and a need to be informed on what to do. In some cases, the measures taken against the spread of the virus may have been overdone, but that’s part of the process. The effect was also international, affecting many suppliers across the globe as well as customers. The Ems-Chemie group has weathered crises before, however, and certain practices have proven tried and true, such as considering the situation during and after the crisis ends and evaluating what changes will stay and which will revert to their earlier state. Personally, Magdalena Martullo-Blocher is counting on a COVID-free 2021 business considering the measures already taken and the economically dire prospect of another lockdown. Independence is also a topic of the discussion, and how it is necessary, at the very least in the long-term, to persevere.